A phase IIb randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients (Special Purpose Grant BTCCRC) (2012–2015)
Grant type:
Royal Brisbane & Women's Hospital Research Foundation